References
Australian Therapeutic Trial in Mild Hypertension: Report by the Management Committee. Lancet 1: 1261–1267 (1980).
Balin, L.J.; Bulpitt, C.J.; Coles, E.C.; Dollery, C.T.; Gear, J.S.W.; Harper, G.; Johnson, B.F.; Munro-Faure, A.D. and Turner, S.C.: Long-term anti-hypertensive drug treatment and blood pressure control in 3 hospital hypertension clinics. British Heart Journal 43: 74–79 (1980).
Bauer, J.H. and Brooks, C.S.: The long-term effect of propranolol on renal function. American Journal of Medicine 66: 405–410 (1979).
Brunner, H.R.; Laragh, J.H.; Baer, L; Newton, M.A.; Goodwin, F.T.; Krakoff, L.R.; Bard, R.H. and Buhler, F.R.: Essential hypertension: Renin and aldosterone, heart attack and stroke. New England Journal of Medicine 286: 441–449 (1972).
Buhler, F.R.; Laragh, J.G.; Baer, L.; Vaughan, E.D. and Brunner, H.R.: Propranolol inhibition of renin secretion. New England Journal of Medicine 287: 209–214 (1972).
Bullen, M.U.; Whitworth, J.A. and Kincaid-Smith, P.: Comparison of single dose and twice daily timolol therapy in mild hypertension. Medical Journal of Australia 2: 514–515 (1980).
Bulpitt, C.J.; Hoffbrand, B.I. and Dollery, C.T.: Contribution of drug treatment to symptoms of hypertension in patients; in Gross and Strasser (Eds) Mild hypertension: Natural History and Management, pp.291–302 (Pitman Medical, London 1979).
Carney, S.; Gillies, A.I. and Morgan, T.: Optimal dose of a thiazide diuretic. Medical Journal of Australia 2: 692–693 (1976).
Curtis, J. and Horrigan, F.: Chlorthalidone induced hyperosmolar hyperglycaemic non ketotic coma. Journal of the American Medical Association 220: 1592–1593 (1972).
Doyle, A.E.: When to begin treatment in hypertension; in Kincaid-Smith and Whitworth (Eds) Hypertension: Mechanisms and Management (ADIS Press, Sydney, in press 1982).
Doyle, A.E.; Jerums, G.; Johnston, C.I. and Louis, W.J.: Plasma renin levels in vascular complications in hypertension. British Medical Journal 2: 206–207 (1973).
Editorial: Hypertension in the over-sixties. Lancet 1: 1396 (1980).
Finnerty, F.A.; Maxwell, M.H.; Lunn, J. and Moser, M.: Long-term effects of furosemide and hydrochlorothiazide patients with essential hypertension. Angiology 28: 125–133 (1977).
Goldman, A.; Stelle, B.; Schnaper, H.; Fitz, A.; Frohlich, E. and Perry, H.M.: Serum lipoprotein levels during chlorthalidone therapy. Journal of the American Medical Association 244: 1691–1695 (1980).
Grimm, R.H.; Leon, A.S.; Hunninghake, D.B.; Lenz, K.; Hannan, P. and Blackburn, H.: Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. Annals of Internal Medicine 94: 7–11 (1981).
Harington, M.; Kincaid-Smith, P. and McMichael, J.: Results of treatment in malignant hypertension: A 7 year experience in 94 cases. British Medical Journal 2: 969–980 (1959).
Isles, C.; Brown, J.J.; Cuming, A.M.M.; Lever, A.F.; McAreavey, D.; Robertson, J.A.S.; Hawthorne, V.M.; Stewart, G.M.; Robertson, J.W.K. and Wapshaw, J.: Excess smoking in malignant phase hypertension. British Medical Journal 1: 579–581 (1979).
Jones, B. and Nanra, R.S.: Double blind trial of anti-hypertensive effect of chlorothiazide in severe renal failure. Lancet 2: 1258–1260 (1979).
Kincaid-Smith, P.; McMichael, J. and Murphy, E.A.: The clinical course and pathology of hypertension with papilloedema (malignant hypertension). Quarterly Journal of Medicine, New Series XXVII: 117–153 (1958).
Kohner, E.M.; Dollery, C.T.; Lowry, C. and Schumer, B.: Effect of diuretic therapy on glucose tolerance in hypertensive patients. Lancet 1: 986–990 (1971).
Laver, M.C.; Fang, P. and Kincaid-Smith, P.: Double-blind comparison of two beta-blocking drugs with previous therapy in the treatment of hypertension. Medical Journal of Australia 1: 174–176 (1974).
Leren, P.; Foss, P.O.; Helgeland, A.; Hjermann, I.; Holme, I. and Lund-Larsen, P.G.: Effect of propranolol and prazosin on blood lipids. Lancet 2: 4–6 (1980).
Medical Research Council Working Party Report on Mild to Moderate Hypertension: Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 2: 539–543 (1981).
Metropolitan Life Insurance Company: Blood pressure: Insurance experience. Metropolitan Life Insurance Co.; New York (1961).
Morgan, T.: Beta-adrenoreceptor blocking drugs in the treatment of hypertension. Australia and New Zealand Journal of Medicine 6: 612 (1976).
Morgan, T.O.; Adam, W.R.; Hodgson, M. and Myers, J.: Duration of effect of different diuretics. Medical Journal of Australia 2: 315–316 (1979a).
Morgan, T.; Myers, J. and Carney, S.: The evidence that salt is an important aetiological agent, if not the cause of hypertension. Clinical Science 57: 457S–462S (1979b).
Morgan, T.O.; Adam, W.R.; Hodgson, M. and Gibberd, R.S.: Failure of therapy to improve prognosis in elderly males with hypertension. Medical Journal of Australia 2: 27–31 (1980).
Mroczek, W.J.; Finnerty, F.A. and Catt, K.F.: Lack of association between plasma renin and history of heart attack or stroke in patients with essential hypertension. Lancet 2: 464–468 (1973).
Norwegian Multicenter Study Group: Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. New England Journal of Medicine 304: 801–807 (1981).
Parijs, J.; Joossens, J.V.; van der Linden, L.; Verstreken, G. and Amery, A.K.P.C: Moderate sodium restriction and diuretics in the treatment of hypertension. American Heart Journal 85: 22–34 (1973).
Reisen, E.; Abel, R.; Modan, M.; Silverberg, D.S.; Eliahou, H.E. and Modan, B.: Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. New England Journal of Medicine 198: 1–6 (1978).
Rudd, P.; Beilston, B.; Tul, V. et al.: Once daily regimen for propranolol antihypertensive therapy. Current Therapeutic Research 27: 29–39 (1980).
Schnaper, H.; Fitz, A.; Frohlich, E.; Goldman, A.; Perry, H.M. and Steele, B.: Chlorthalidone and serum cholesterol. Lancet 2: 295 (1977).
Shaw, J.; England, J.D.F. and Hua, A.S.P.: Beta-blockers and plasma triglycerides. British Medical Journal 1: 986 (1978).
Tanaka, A.N.; Sagaguchi, K.; Oshige, K.; Niimura, T. and Kinehisa, T.: Effect of chronic administration of propranolol on lipoprotein composition. Metabolism 25: 170–175 (1976).
Tarazi, R.C.; Dustan, H.P. and Frohlich, E.D.: Long-term thiazide therapy in essential hypertension. Circulation 41: 709–717 (1970).
Tweeddale, N.G. and Fodor, G.J.: Elevated serum uric acid: A cardiovascular risk factor? Nephron 23(Suppl. 1): 3–6 (1979).
van den Brink, G.; Boer, P.; van ästen, P.; Dorhout Mees, E.J. and Geyskes, G.G.: One and three doses of propranolol a day in hypertension. Clinical Journal of Pharmacology and Therapeutics 27: 9–15 (1980).
Veterans’ Administration Co-operative Study Group on Anti-hypertensive Agents. Journal of American Medical Association 213: 1143–1152 (1970).
Waal-Manning, H.J.: Metabolic effects of β-adrenoreceptor blockers. Drugs 11(Suppl. 1): 121–126 (1976).
Waal-Manning, H.J.: β-Blockers and labetalol. Current Therapeutics 22(6): 101–113 (1981).
Walker, R.G.; Young, C.K.; Hua, A.S.P.; Thomas, G.W.; Whitworth, J.A. and Kincaid-Smith, P.S.: Tienilic acid in the treatment of mild to moderate hypertension. Clinical and Experimental Pharmacology and Physiology 7: 473–476 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Whitworth, J.A., Kincaid-Smith, P. Diuretics or β-Blockers First for Hypertension?. Drugs 23, 394–402 (1982). https://doi.org/10.2165/00003495-198223050-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198223050-00004